-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, August 2 News On the evening of July 30, the official website of the National Medical Insurance Administration issued an announcement on the announcement that the adjustment of the National Medical Insurance Drug Catalogue for 2021 passed the preliminary form of review of drugs and information
.
271 drugs passed the preliminary formal review
.
.
271 drugs passed the preliminary formal review
.
The document shows that from 9:00 on July 1, 2021 to 17:00 on July 14, 2021, the National Medical Insurance Bureau received a total of 501 pieces of enterprise declaration information, involving 474 drugs
.
After review, 271 drugs passed the preliminary formal review
.
Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
02%
.
.
After review, 271 drugs passed the preliminary formal review
.
Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
02%
.
The National Medical Insurance Bureau stated that the drugs and related information that have passed the preliminary formal review will be publicized in accordance with the procedures, and the publicity time will be July 30-August 5, 2021
.
The specific list is as follows:
.
The specific list is as follows:
Medical Network, August 2 News On the evening of July 30, the official website of the National Medical Insurance Administration issued an announcement on the announcement that the adjustment of the National Medical Insurance Drug Catalogue for 2021 passed the preliminary form of review of drugs and information
.
271 drugs passed the preliminary formal review
.
.
271 drugs passed the preliminary formal review
.
The document shows that from 9:00 on July 1, 2021 to 17:00 on July 14, 2021, the National Medical Insurance Bureau received a total of 501 pieces of enterprise declaration information, involving 474 drugs
.
After review, 271 drugs passed the preliminary formal review
.
Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
02%
.
.
After review, 271 drugs passed the preliminary formal review
.
Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
02%
.
The National Medical Insurance Bureau stated that the drugs and related information that have passed the preliminary formal review will be publicized in accordance with the procedures, and the publicity time will be July 30-August 5, 2021
.
The specific list is as follows:
.
The specific list is as follows:
Medical Network, August 2 News On the evening of July 30, the official website of the National Medical Insurance Administration issued an announcement on the announcement that the adjustment of the National Medical Insurance Drug Catalogue for 2021 passed the preliminary form of review of drugs and information
.
271 drugs passed the preliminary formal review
.
.
271 drugs passed the preliminary formal review
.
The document shows that from 9:00 on July 1, 2021 to 17:00 on July 14, 2021, the National Medical Insurance Bureau received a total of 501 pieces of enterprise declaration information, involving 474 drugs
.
After review, 271 drugs passed the preliminary formal review
.
Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
02%
.
Enterprise enterprise enterprise medicine medicine medicine.
After review, 271 drugs passed the preliminary formal review
.
Among the non-catalog drugs that passed the preliminary formal review, the newly marketed drugs after 2016 accounted for 93.
02%
.
The National Medical Insurance Bureau stated that the drugs and related information that have passed the preliminary formal review will be publicized in accordance with the procedures, and the publicity time will be July 30-August 5, 2021
.
The specific list is as follows:
.
The specific list is as follows: